Welcome to our dedicated page for Earth Science Te news (Ticker: ETST), a resource for investors and traders seeking the latest updates and insights on Earth Science Te stock.
Earth Science Tech, Inc. (OTC: ETST) is a Florida-based strategic holding company focused on healthcare, pharmaceutical preparations, real estate development, and consumer brands. Its news flow provides insight into how the company executes its strategy of acquiring, optimizing, and managing operating businesses across compounding pharmacies, telemedicine platforms, brick-and-mortar healthcare, and direct-to-consumer products.
Investors following ETST news will find regular updates on regulatory milestones, financial performance, and portfolio developments. Recent releases highlight the company’s formal identification under SIC code 2834 as a pharmaceutical entity, its transition away from legacy CBD-related classifications, and its engagement with investor relations firms to expand outreach. News items also cover its qualification for the OTCID tier of the OTC Markets and FINRA’s processing of a Form 211 for the initiation of priced quotations.
Operational updates frequently focus on subsidiaries such as RxCompoundStore.com and Mister Meds, both compounding pharmacies; Peaks Curative, a telemedicine referral platform; Las Villas Health Care, a healthcare facility serving the Spanish-speaking community; DOConsultations, which coordinates home therapies; Avenvi, a real estate and investment arm; and MagneChef, a direct-to-consumer brand built on patents and intellectual property. Company news has also detailed actions around its share repurchase program and amendments to authorized share levels.
This page aggregates these disclosures so readers can track earnings announcements, regulatory filings referenced in press releases, pharmacy and telemedicine expansion, real estate initiatives, and consumer brand developments. For those researching ETST, the news stream offers a consolidated view of how Earth Science Tech communicates its progress, portfolio changes, and capital allocation decisions over time.
Earth Science Tech, Inc. (ETST) will announce its financial results for the second quarter of fiscal 2023, ending September 30, 2022, on November 14, 2022, at 4:00 PM ET. Following this, a conference call will be held at 5:00 PM ET to discuss the results, including highlights and future outlook. The Company is in a pending transaction to enter compounding pharmaceuticals and telemedicine, which indicates a strategic shift towards expanding its healthcare services.
Earth Science Tech, Inc. (OTC: ETST) announces the Phase I acquisition of RxCompoundstore.com, LLC. and Peaks Curative, LLC. as part of a new strategic direction. Both entities are now wholly owned subsidiaries, enhancing ETST's expansion efforts. RxCS's operations will be led by Mario Tabraue, who plans to launch Peaks Curative's website and product line soon. The acquisition aims to increase revenue through compounding injectables and a marketing strategy involving influencers. Phase II acquisition is expected in 2022, potentially leading to a name and ticker change.
Earth Science Tech, Inc. (OTC: ETST) has announced a dual-phase acquisition strategy involving RxCompoundstore.com, Peaks Curative, and JCR Medical Equipment to enhance its market positioning in the pharmaceutical compounding, telemedicine, and medical equipment sectors. Phase I, set to start in October 2021, includes RxCS and PC, targeting a collective market worth over $73 billion with a CAGR of 11.5%. Phase II will involve JCR, aiming for a market estimated at $1 billion with a CAGR of 6.4%. The acquisitions aim to maximize shareholder value and integrate operations efficiently.
Earth Science Tech, Inc. (OTC: ETST) has regained its current status with the SEC, filing delinquent reports for both the year-end and quarterly periods. This recovery was facilitated by new receiver William A. Leonard, who replaced former receiver Robert L. Stevens amidst shareholder litigation. The company is also pursuing acquisitions, including JCR Medical Equipment, enhancing its operational capacity with new office space. Additionally, ETST is in talks to license its medical device, HygeeTM, while continuing to sell remaining inventory of hemp products.